Company Description
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide.
Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations.
The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them.
It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions.
The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.
Country | United States |
IPO Date | Jun 17, 2021 |
Industry | Medical - Diagnostics & Research |
Sector | Healthcare |
Employees | 53 |
CEO | Leslie Hoyt |
Contact Details
Address: 450 Bedford Street Lexington, Massachusetts United States | |
Website | https://ispecimen.com |
Stock Details
Ticker Symbol | ISPC |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001558569 |
CUSIP Number | 45032V108 |
ISIN Number | US45032V1089 |
Employer ID | 27-0480143 |
SIC Code | 8731 |
Key Executives
Name | Position |
---|---|
Annette Arnold | Vice President of Sales & Business Development |
Brielan Smiechowski | Senior Vice President of Business Development |
Carly Lejnieks | Vice President of Marketing |
Evan Cox | Senior Vice President of Strategy & Innovation |
Leslie Hoyt | Senior Vice President of Operations |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 12, 2024 | 8-K | Current Report |
Nov 12, 2024 | 8-K | Current Report |
Nov 07, 2024 | 10-Q | Quarterly Report |
Oct 31, 2024 | 8-K | Current Report |
Oct 31, 2024 | 424B4 | Filing |
Oct 18, 2024 | S-1 | Filing |
Oct 02, 2024 | 8-K | Current Report |
Sep 30, 2024 | 4 | Filing |
Sep 30, 2024 | 3 | Filing |
Sep 27, 2024 | 4 | Filing |